Heterocyclic modulators of HIF activity for treatment of disease
申请人:Board of Regents, University of Texas System
公开号:US10208059B2
公开(公告)日:2019-02-19
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.